Evidence map›Paper›PMID 42015789›Full record

ReviewJournal of traditional Chinese medicine = Chung i tsa chih ying wen pan2026

Therapeutic potential of garlic-derived exosome like nanovesicles: challenge and opportunity.

Masoumeh Amiri, Mozafar Khazaei, Tayebeh Sadat Tabatabai, Leila Rezakhani

Abstract readReview
In one paragraph

Review in Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Masoumeh AmiriClinical Research Development Center,Imam Khomeini and Mohammad Kermanshahi and Farabi Hospitals, Kermanshah University of Medical Sciences,Kermanshah 6715847141,Iran.
Mozafar KhazaeiDepartment of Tissue Engineering,School of Medicine, Kermanshah University of Medical Sciences,Kermanshah 6715847141,Iran.
Tayebeh Sadat TabatabaiStudent Research Committee,School of Medicine, Shahroud University of Medical Sciences,Shahroud 36147-73943,Iran.
Leila RezakhaniDepartment of Tissue Engineering,School of Medicine, Kermanshah University of Medical Sciences,Kermanshah 6715847141,Iran.

Funding

Kermanshah University of Medical Sciences, Kermanshah, Iran IR.KUMS.AEC.1402.036
6 · The paper itself

Abstract

Recent advancements in nanotechnology have catalyzed interest in exosome-like nanovesicles derived from garlic, exploring their potential therapeutic applications. This review assesses the therapeutic efficacy of garlic-derived exosome-like nanovesicles (GaELNVs), emphasizing their antimicrobial, anticancer, antioxidant, and anti-inflammatory properties, alongside their utility in drug delivery systems. Synthesizing diverse studies, this review discusses methodologies for GaELNV isolation, characterization (including high-speed centrifugation, sequential centrifugation, and sucrose gradient purification), and application. GaELNVs exhibit notable therapeutic potential, evidenced by their capacity to mitigate brain inflammation, enhance cognitive function, improve glucose metabolism, and show minimal immunogenicity. These effects are attributed to their modulation of inflammatory cytokines and other molecular pathways. Moreover, GaELNVs demonstrate robust biocompatibility, stability in acidic environments, and efficient targeting capabilities. In conclusion, this review underscores the promising therapeutic applications of GaELNVs, particularly as a pioneering drug delivery system. However, further investigations are imperative to optimize clinical deployment and comprehensively elucidate their mechanisms of action.

Indexed as

ExosomesGarlicNanoparticlesAnimalsAnti-Inflammatory AgentsDrug Delivery SystemsHumansAnti-Inflammatory Agentsexosomegarlicnanovesiclesreviewtherapeutic

Identifiers

PMID42015789
PMCPMC13077103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.